Contrast echocardiography: Review and future directions

American Journal of Cardiology

Volumn 81, Issue 12 A, 1998, Pages 41G-48G

  Cheng, Shi Chi ^a   Dy, Timothy C ^a   Feinstein, Steven B ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOME; ALBUMIN; ALBUNEX; BY 963; CONTRAST MEDIUM; FLUOROCARBON; FS 069; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; QUANTISON; SHU 508; SONOVUE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTRAST ECHOCARDIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART DISEASE; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE QUALITY; PRIORITY JOURNAL;

EID: 0032543729     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00053-8     Document Type: Conference Paper

References (81)

1. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-366.
2. McKay RS, Rubissow G. Decompression studies using ultrasonic imaging of bubbles. IEEE Trans BME 1978;25:2537-2544.
3. Ziskin MC, Bonakdapour A, Weinstein DP, Lynch PR. Contrast agents for diagnostic ultrasound. Invest Radiol 1972;7:500-505.
4. Meltzer RS, Tickner EG, Sahines T, Popp RL. The source of ultrasound contrast effects. J Clin Ultrasound 1980;18:121-127.
5. Feigenbaum H, Stone JM, Lee DA. Identification of ultrasound echoes from the LV by the use of indocyanine green. Circulation 1970;41:613-620.
6. Grinstaff MW, Suslick K. An air-filled proteinaceous microbubble. Synthesis of a new echo-contrast agent. Proc Natl Acad Sci USA 1990;88:7708-7710.
7. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319-333.
8. Bommer WJ, Shah PM, Allen H, Meltzer R, Kisslo J. The safety of contrast echocardiography: report of the committee on contrast echocardiography for the American Society of Echocardiography. J Am Coll Cardiol 1984;3:6-13.
9. Feinstein SB, TenCate F, Werner Z, Ong K, Maurer G, Tei C, Shah PM, Meerbaum S, Corday E. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 1984;3:14-20.
10. Powsner S, Wood J, Prieto P. High speed interface for myocardial sonicated contrast studies. (Abstr.) SPIE 1989;845:384.
11. Kondo S, Tei C, Meerbaum S, Corday E, Shah PM. Hyperemic response of intracoronary contrast agents during echocardiographic delineation of regional myocardium. J Am Coll Cardiol 1984;4:149-156.
12. Barnhart J, Leven H, Villapando E. Characteristics of Albunex: Air-filled microspheres for echocardiography contrast enhancement. Invest Radiol 1990; 25:S162-S164.
13. Keller MW, Glahseen W, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr 1989;2:48-52.
14. Feinstein SB, Cheirif J, Ten Cate FJ. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter results. J Am Coll Cardiol 1990;16:316-324.
15. Porter T, Xie F, Kilzer K. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial contrast which correlates with coronary blood flow. J Am Soc Echocardiogr 1995;8:710-718.
16. Albers VM. Underwater Acoustic Handbook. Hershey, PA: Pennsylvania State University Press, 1960.
17. Quay SC. Ultrasound contrast agent development: phase shift colloids. (Abstr.) J Ultrasound Med 1994;13:S9.
18. Quay SC. Microbubble-based ultrasound contrast agents: the role of gas selection in microbubble persistence. (Abstr.) J Ultrasound Med 1994;13:S9.
19. Ten Cate FJ, Aiazian A, de Jong N. Advances in clinical contrast echocardiography: the Thoraxcentre experience. The Thoraxcentre J 1995;7:13-14.
20. Grouse L, Cheirif J, Hanley D, Kisslo J, Labovitz A, Raichlen J, Schutz R, Shah P, Smith M. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol 1993;22:1494-1500.
21. de Jong N. Basic principles of ultrasound contrast agents. In: de Jong N, ed. Acoustic Properties of Ultrasound Contrast Agents. Woerden, The Netherlands: Zuidam and Zonen, 1993:17-36.
22. Heidenreich PA, Harper PV, Chen TW, Dick CD, Feinstein SB. Contrast echo measurement of myocardial perfusion: standardization. (Abstr.) Circulation 1988;4(suppl II):566.
23. Reisner SA, Shapiro JR, Amico AF, Meltzer RS. Contrast agents for myocardial perfusion studies. Mechanisms, state of the art, and future prospects. In: Meerbaum S, Meltzer R, eds. Myocardial Contrast Two-dimensional Echocardiography. Dordrecht: Kluwer Academic, 1989;45-59.
24. Feinstein SB, Voci P, Segil LJ, Harper PV. Contrast echocardiography. In: Marcus ML, Skorton DJ, Schelbert HR, Wolf GL, eds. Cardiac Imaging: A Companion to Braunwald's Heart Disease. Philadelphia: WB Saunders, 1991; 557-574.
25. Hamilton WF, Remington JW. Comparison of the time concentration curves in arterial blood of diffusible and nondiffusible substances when injected at a constant rate and when injected instantaneously. Am J Physiol 1947;148:35-39.
26. Rovai D, Lombardi M, Ghelardini G, Marzilli M, Taddei L, Michelassi C, Distante A, DeMaria AN, L'Abbate A. Discordance between responses of contrast echo intensity to increased flow rate in human coronary circulation and in vitro. Am Heart J 1992;124:398-404.
27. Walker R, Wiencek JG, Aronson S. The influence of intravenous Albunex injection on pulmonary hemodynamics, gas exchange and left ventricular peak intensity. J Am Soc Echocardiogr 1992;5:462-470.
28. Powsner SM, Feinstein SB, Keller MW, Saniie J. Quantitation of echocontrast effects. Am J Physiol Imaging 1986;1:124-128.
29. Rovai D, DeMaria A, L'Abbate A. Myocardial contrast echo effect: the dilemma of coronary blood flow and volume. J Am Coll Cardiol 1995;26:12-17.
30. Rovai D, Lombardi M, Taddei L. Mazzarisi A, Landini L, Ghelardini G, Distante A, Benassi A, L'Abbate A. Flow quantitation by contrast echocardiography: effects of intervening tissue and of the angle of incidence between flow and ultrasonic beam. Int J Card Imaging 1993;9:21-27.
31. Winkelmann JW, Feinstein SB. Contrast echocardiography. In: St. John Sutton MG, Oldershaw PJ, Kotler MN, eds. Textbook of Echocardiography and Doppler in Adults and Children. 2nd ed. Oxford, UK: Blackwell Science, 1994:507-515.
32. Block RJ, Brodsky L, Ostoic T, Fernandez A, Hickle P, Devries S, Bieniarz T, In M, Feinstein SB. Optimizing Albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans. J Am Soc Echo 1996;9:787-794.
33. Wei K, Skyba D, Firshke C, Jayaweera A, Lindner J, Kaul S. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol 1997;29:1081-1088.
34. Gandhok N, Block R, Ostoic T, Rawal M, Hickle P, Devries S, Feinstein SB. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. J Am Soc Echo 1997;10:25-30.
35. Burns PN, Powers JE, Simpson DH, Uhlendorf V, Fritzsche T. Harmonic imaging: principles and preliminary results. Clin Radiol 1996;51(suppl I):50-55.
36. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent. Ultrason Imaging 1992;14:134-158.
37. de Jong N. Background. In: de Jong N, ed. Acoustic Properties of Ultrasound Contrast Agents. Woerden, The Netherlands: Zuidam and Zonen, 1993;1-16.
38. Porter TM, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1992;92: 2391-2395.
39. Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81.
40. Yvorchuk KJ, Sochowski RA, Chan KL. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization. J Am Soc Echo 1996;9:462-469.
41. Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440-1443.
42. Voci P, Testa G, Feinstein SB. Enhancement of endocardial border detection by intravenous contrast injection during stress echocardiography. Cardiovascular Imaging 1996;8:285-287.
43. Marcovitz P, Armstrong W. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992;69:1269-1273.
44. Nihoyannopoulos P. Stress echo using ultrasound contrast agents. (Abstr.) Presented at the First Europe Symposium on Ultrasound Contrast Imaging. Rotterdam, The Netherlands. January 25-26, 1996.
45. Kemper AJ, Force T, Kloner R. Contrast echocardiographic estimation of regional myocardial blood flow after acute coronary occlusion. Circulation 1985; 72:1115-1124.
46. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation 1993;88:596-604.
47. Ten Cate FJ, Drury K, Meerbaum S, Noorsdy J, Feinstein SB, Shah PM, Corday E. Myocardial contrast two-dimensional echocardiography: experimental examination at different coronary flow levels. J Am Coll Cardiol 1984;3:1219-1226.
48. McKay RG, Pfeffer MA, Pastermak RC, Marikis JE, Come PC, Nakao S, Alderman JK, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986; 74:693-702.
49. Ito H, Maruyama A, Iwakura K, Takiuchi S, Minamino T. Clinical implications of the "no-reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
50. DeMaria AN, Bommer WJ, Riggs K, Mason DT. Echocardiographic visualization of myocardial perfusion by left heart and intracoronary injection of echo contrast agent. (Abstr.) Circulation 1980;62(suppl III)III-143.
51. Tei C, Sakamaki T, Shah PM, Corday E. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits. Circulation 1983;67:585-593.
52. Armstrong WF, West SR, Mueller TM, Dillon JC, Feigenbaum H. Assessment of location and size of myocardial infarction with contrast-enhanced echocardiography. J Am Coll Cardiol 1983;2:63-69.
53. Kaul S, Pandian NG, Okada RD, Weiman AE. Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk." J Am Coll Cardiol 1984;4:1272-1282.
54. Feinstein SB, Shah PM, Bing RJ, Meerbaum S, Corday E, Chang BL, Santillan G, Fujibayashi Y. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol 1984;4:595-600.
55. Cheirif J, Yamamoto H, Zoghbi WA, Quinones MA. Demonstration of physiologic transit time of sonicated meglumine diatrizoate in a microvascular preparation. J Cardiovasc Ultrasound 1987;6:245-247.
56. Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: comparison with radiolabeled red blood cells. Circ Res 1994;74:1157-1165.
57. Porter T, Xie F, Kricsfeld A, Kilzer K. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin. J Am Coll Cardiol 1995; 26:33-40.
58. Mudra H, Zwehl W, Klauss V, Haufe M, Spes C, Theisen K. Myocardial contrast echocardiography with sonicated ioprimide (Ultravist 370) before and after coronary angioplasty. Z Kardiol 1991;80:367-372.
59. Reisner SA, Ong LS, Lichtenberg GS, Shapiro J, Amico A, Allen M, Meltzer R. Quantitative assessment of the immediate results of coronary angioplasty by myocardial contrast echocardiography. J Am Coll Cardiol 1989;13:852-859.
60. Jayaweera A, Sklenar J, Kaul S. Quantification of images obtained during myocardial contrast echocardiography. Echo 1994;11:385-396.
61. Kenner M, Zajac E, Kondos GT, Dave R, Winkelmann JW, Joftus J, Laucevicius A, Kybarskis A, Berukstis E, Urbonas A, Feinstein SB. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995;76:861-868.
62. Nanto S, Lim YJ, Masuyama T, Hori M, Nagata S. Diagnostic performance of myocardial contrast echocardiography for detection of stunned myocardium. J Am Soc Echocardiogr 1996;9:314-319.
63. Camarano G, Ragosta M, Gimple L, Powers ER, Kaul S. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995;75:215-219.
64. Villanueva F, Glasheen W, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography: implication in determining extent of myocardial salvage. Circulation 1993;88:2596-2606.
65. Widimsky P, Cornel JH, Ten Cate FJ. Evaluation of collateral blood flow by myocardial contrast-enhanced echocardiography. Br Heart J 1988;59:20-22.
66. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii D, Masuyama T, Ketabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
67. Sabia P, Powers E, Jayaweera AR, Ragosta M, Kaul S. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. Circulation 1990;16:1594-1600.
68. Reisner SA, Ong LS, Fitzpatrick PG, Lichtenberg GS, Sullebarger JT, Allen MN, Meltzer RS. Evaluation of coronary flow reserve using myocardial contrast echocardiography in humans. Eur Heart J 1992;13:389-394.
69. Goldman ME, Mindich BP. Intraoperative cardioplegia contrast echocardiography for assessing myocardial perfusion during open heart surgery. J Am Coll Cardiol 1984;4:1029-1034.
70. Smith J, Feinstein SB, Kapelanski DP, Karp R, Roizen M. Transesophageal echocardiographic determination of myocardial perfusion during cardiac surgery. (Abstr.) Circulation 1986;74(suppl II):475.
71. Aronson S, Lee BK, Zaroff JG, Wiencek J, Walker R, Feinstein SB, Karp R. Myocardial distribution of retrograde delivered cardioplegia in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 1993;105:214-221.
72. Partington MT, Acar C, Buckberg GP, Julia P, Kofsky E, Bugyi H. Studies of retrograde cardioplegia: I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg 1989;97:605-612.
73. Meza M, Kates M, Barbee W, Revall S, Perry B, Murgo JP, Cheirif J. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium. J Am Coll Cardiol 1997; 29:974-984.
74. Bolognese L, Antoniucci D, Rovai D, Buonamici P, Cerisano G, Santoro GM, Marini C, L'Abbate A, Fazzini PF. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996;28:1677-1683.
75. von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. J Am Coll Cardiol 1995;25:500-508.
76. von Bibra H, Becher H, Firschke C, Schlief R, Emslander HP, Schömig A. Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a saccharide-based contrast Agent. J Am Coll Cardiol 1993;22:521-528.
77. Terasawa A, Miyatake K, Nakatani S, Yamagishi M, Matsuda H, Beppu S. Enhancement of Doppler flow signals in the left heart chambers by intravenous injection of sonicated albumin. J Am Coll Cardiol 1993;21:737-742.
78. Kemp WE Jr, Kerins D, Shyr Y, Byrd BF III. Optimal Albunex dosing for enhancement of Doppler tricuspid regurgitation spectra. Am J Cardiol 1997;79: 232-234.
79. Nakatani S, Imanishi T, Terasawa A, Beppu S, Nagata S, Miyatake K. Clinical application of transpulmonary contrast-enhanced Doppler technique in the assessment of severity of aortic stenosis. J Am Coll Cardiol 1992;20:973-978.
80. Firschke C, Lindner JR, Goodman NC, Skyba D, Wei K, Kaul S. Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of microbubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory. J Am Coll Cardiol 1997;29:207-216.
81. Porter TR, Li S, Kricsfeld D, Armbruster RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol 1997;29:791-799.